zovir 40 mg/ml oral suspension
glaxosmithkline pharma a/s - aciclovir - oral suspension - 40 mg/ml
zovir 80 mg/ml oral suspension
glaxosmithkline pharma a/s - aciclovir - oral suspension - 80 mg/ml
zovir 200 mg tabletter
glaxosmithkline pharma a/s - aciclovir - tabletter - 200 mg
tern emulsionskoncentrat
syngenta nordics a/s - fenpropidin - emulsionskoncentrat - 750 g/l fenpropidin
entecavir mylan
mylan pharmaceuticals limited - entecavir monohydrat - hepatitis b - antivirale midler til systemisk anvendelse - entecavir mylan is indicated for the treatment of chronic hepatitis b virus (hbv) infection in adults with:compensated liver disease and evidence of active viral replication, persistently elevated serum alanine aminotransferase (alt) levels and histological evidence of active inflammation and/or fibrosis. dekompenseret leversygdom. for både erstatning og dekompenseret leversygdom, denne angivelse er baseret på data fra kliniske forsøg i nukleosid naive patienter med hbeag-positive og hbeag negativ hbv-infektion. med hensyn til patienter med lamivudin-ildfast hepatitis b. entecavir mylan er også indiceret til behandling af kronisk hbv infektion i nukleosid naive pædiatriske patienter fra 2 til.
abacavir/lamivudine "glenmark" 600+300 mg filmovertrukne tabletter
glenmark arzneimittel gmbh - abacavirhydrochlorid, lamivudin - filmovertrukne tabletter - 600+300 mg
tenofovir disoproxil "glenmark" 245 mg filmovertrukne tabletter
glenmark arzneimittel gmbh - tenofovir disoproxilphosphat - filmovertrukne tabletter - 245 mg
darunavir "medical valley" 800 mg filmovertrukne tabletter
medical valley invest ab - darunavirpropylenglycolat - filmovertrukne tabletter - 800 mg
emtricitabine/tenofovir disoproxil "glenmark" 200+245 mg filmovertrukne tabletter
glenmark arzneimittel gmbh - emtricitabin, tenofovir disoproxilphosphat - filmovertrukne tabletter - 200+245 mg
famvir 500 mg filmovertrukne tabletter
nordic prime aps - famciclovir - filmovertrukne tabletter - 500 mg